Aging brings two opposing trends in cancer risk: first, the risk climbs in our 60s and 70s, as decades of genetic mutations ...

Large-scale protein and gene profiling have massively expanded the landscape of cancer-associated proteins and gene mutations ...

Scientists identified early genetic mutations in healthy women’s breast cells that may lead to breast cancer, particularly in ...

The accelerated approval is part of the FDA’s Project FrontRunner, aimed at advancing cancer drug development.

Women who underwent bilateral mastectomy or removal of ovaries and Fallopian tubes had lower rates of recurrence, ovarian ...

AstraZeneca (NASDAQ:AZN) said its drug Tagrisso has been approved by EU regulators for the treatment of EGFR-mutation ...

New research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning ...

NCCN Guidelines for Cervical Cancer now include Puma's neratinib monotherapy for 2nd line or later use in patients with ...

A once-a-day tablet for advanced breast cancer will be rolled out on the NHS. More than 1,000 women will be eligible for the ...

Pfizer’s BRAFTOVI combination regimen receives US FDA approval for treatment of metastatic colorectal cancer: New York Monday, December 23, 2024, 10:00 Hrs [IST] Pfizer Inc anno ...